Apixaban has received a positive opinion from the CHMP, for the prevention of VTE in adult patients who have undergone elective hip or knee replacement surgery. Approval is almost certain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.